Workflow
万辰集团(300972) - 2024 Q1 - 季度财报
300972Wanchen Group(300972)2024-04-26 11:21

Revenue and Profitability - The company's revenue for Q1 2024 reached ¥4,830,392,702.55, a significant increase of 534.03% compared to ¥761,856,083.40 in the same period last year[5]. - Net profit attributable to shareholders was ¥6,238,216.19, reflecting a decrease of 88.15% from ¥52,633,490.70 year-on-year[5]. - The company's basic earnings per share dropped by 88.68% to ¥0.0388 from ¥0.3429 in the same quarter last year[5]. - The total profit for the current period was ¥113,126,326.15, compared to ¥47,801,971.83 in the previous period, representing an increase of approximately 136.5%[27]. Cash Flow - The net cash flow from operating activities surged by 835.22% to ¥275,974,753.98, up from ¥29,509,230.84 in the previous year[5]. - The net cash flow from operating activities for Q1 2024 was approximately $275.97 million, representing an increase of 835.22% compared to $29.51 million in Q1 2023, primarily due to significant growth in the bulk snack business[15]. - The net cash flow from financing activities for Q1 2024 was approximately $264.46 million, reflecting a 172.39% increase from $97.09 million in Q1 2023, primarily due to successful equity financing during the reporting period[15]. - The company reported a net cash flow from financing activities of ¥264,457,715.00, compared to ¥97,089,518.02 in the previous period, indicating an increase of about 172.3%[31]. Operating Costs and Expenses - The company reported a 576.99% increase in operating costs, amounting to ¥4,358,301,924.03, compared to ¥643,780,674.80 in Q1 2023[13]. - The company incurred total operating costs of ¥4,722,040,573.06, which is a substantial rise from ¥715,274,945.50 in the previous period, reflecting an increase of about 560.5%[26]. - Research and development expenses rose dramatically by 2309.39% to ¥936,565.28, up from ¥38,871.41 in the previous year[13]. - The company experienced a 392.64% increase in taxes and surcharges, totaling ¥10,877,005.96 compared to ¥2,207,885.18 in the same period last year[13]. Assets and Liabilities - Total assets increased by 12.69% to ¥4,423,342,225.76 from ¥3,925,354,361.68 at the end of the previous year[5]. - The total liabilities rose to CNY 3,424,946,579.55 from CNY 3,229,545,195.69, indicating an increase of approximately 6.1%[24]. - The company's cash and cash equivalents increased to CNY 1,705,130,339.24 from CNY 1,209,689,850.18, reflecting a growth of about 41.0%[23]. - The company's inventory decreased to CNY 691,585,480.08 from CNY 733,288,606.20, a decline of approximately 5.7%[23]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 5,271, with no preferred shareholders having restored voting rights[17]. - The largest shareholder, Fujian Huanxi Grass Agriculture Development Co., Ltd., holds 23.75% of shares, amounting to 40,949,000 shares, with 7,000,000 shares pledged[17]. - The second-largest shareholder, Zhangzhou Jinwancheng Investment Co., Ltd., owns 17.36% of shares, totaling 29,935,000 shares, with no shares pledged[17]. - The third-largest shareholder, Wang Zenning, holds 14.86% of shares, equivalent to 25,619,115 shares, with 7,965,000 shares pledged[17]. Market Strategy and Development - The report indicates ongoing strategies for market expansion and potential new product development, although specific details were not disclosed in the provided content[15]. - The company plans to expand its market presence and enhance product development, focusing on innovative biotechnology solutions[20].